Effects of Conditioning Activities in Female Athletes (PAPE)

April 20, 2026 updated by: Gustavo Ribeiro da Mota, Universidade Federal do Triangulo Mineiro

Effect of Conditioning Activities on Neuromuscular Performance in Female Invasion Sports Athletes

This study will investigate how different warm-up strategies affect physical performance in female athletes who practice invasion sports (e.g., soccer, handball, and basketball). Participants will complete three different conditions: a standard warm-up only, a warm-up followed by a performance-enhancing activity, and a warm-up followed by a low-intensity activity designed to simulate the same expectations without real physiological effects.

After each condition, athletes will perform tests of vertical jump performance and change-of-direction speed. In addition, participants will report their perceived effort, expectations, muscle soreness, and recovery status.

The study will include eighteen female athletes and will be conducted under controlled conditions, including standardized hydration, recovery, and environmental factors. The design will allow comparison of the physical and psychological effects of the different warm-up strategies on performance.

Study Overview

Detailed Description

Post-activation potentiation (PAP) refers to the transient improvement in performance following maximal stimuli, attributed to the phosphorylation of the myosin light chain. However, due to its brief and involuntary nature (typically lasting less than 2 minutes, with a half-life of approximately 28 seconds), its practical contribution is limited.

Based on this, other mechanisms such as increased muscle temperature and water content, enhanced motor unit recruitment, and increased neural excitability appear to have greater practical relevance.

Accordingly, the term post-activation performance enhancement (PAPE) was proposed to describe performance improvements following maximal or submaximal conditioning activities. Its magnitude may vary according to factors such as sex, strength level, recovery time, training experience, and protocol characteristics.

Despite recent advances, the optimal parameters of conditioning activities to maximize PAPE remain inconclusive, and many studies present methodological limitations, such as lack of randomization, blinding, and familiarization procedures.

Furthermore, there is a need to thoroughly explore the role of participants' expectations, as well as to include placebo or nocebo conditions, as these psychophysiological factors may significantly influence performance outcomes. In this context, assessor blinding is essential to reduce potential bias.

In addition, evidence suggests that women may exhibit a greater PAPE response, although they are underrepresented in the literature, accounting for only a small proportion of studied samples. This may be related to lower fatigability and faster recovery following certain types of muscle actions, which could enhance the response to conditioning activities with less interference from fatigue.

Moreover, evidence regarding the effects of PAPE on change-of-direction performance is still limited. Change-of-direction tasks involve acceleration, deceleration, and rapid directional changes, often in response to dynamic sport-specific demands. Therefore, assessing this ability is essential, as it closely reflects the demands of invasion sports.

There is a lack of studies employing rigorous methodologies that adequately control psychophysiological variables such as expectancy and placebo effects, along with proper blinding of both participants and researchers. Additionally, studies focusing on female athletes remain scarce.

Therefore, this study aims to address these gaps using a randomized crossover experimental design with three conditions: a "real" conditioning activity (standardized warm-up followed by drop jumps), a SHAM condition (standardized warm-up followed by low-intensity exercise at 20% of one-repetition maximum with verbal suggestion and simulated occlusion), and a control condition (standardized warm-up only). The study will compare the effects of these conditions on neuromuscular performance and perceptual responses in female athletes.

Study Type

Interventional

Enrollment (Estimated)

20

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

  • Name: Armando Seno Lourenço Silva, Master´s Student
  • Phone Number: 55 17981447702
  • Email: armandoseno95@gmail.com

Study Locations

    • Minas Gerais
      • Uberaba, Minas Gerais, Brazil, 55
        • Federal University of Triângulo Mineiro
        • Contact:
        • Contact:
        • Principal Investigator:
          • Gustavo Ribeiro da Mota, PhD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Female athletes aged 18 to 30 years
  • Familiarity with the proposed tests and exercises
  • Ability to perform all testing procedures
  • Regular participation in invasion team sports (at least two sessions per week) for a minimum of two years

Exclusion Criteria:

  • Presence of musculoskeletal injuries that could limit test performance
  • Injury occurring during the study period
  • Absence for more than seven days between experimental sessions
  • Failure to comply with the data collection schedule

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Conditioning Activity

The "real" conditioning activity will consist of one set of six repetitions of drop jumps performed at maximal intensity. The box height will be individually determined during two familiarization sessions to ensure optimal performance and safety. Each repetition will be separated by a 15-second interval.

Participants will be instructed to step off the box and, upon ground contact, perform the jump as quickly as possible, emphasizing minimal ground contact time and maximal rebound height. Arm swing will be allowed to ensure maximal performance.

This study uses a randomized crossover design in which participants complete three conditions (real conditioning activity, SHAM, and control), reducing inter-individual variability. A key feature is the SHAM condition designed to control for placebo and expectancy effects, combining low-load resistance exercise (20% 1RM), verbal suggestion, and simulated blood flow restriction (15 mmHg), insufficient to induce physiological responses. All conditions are strictly standardized, including a warm-up, metronome-controlled cadence, fixed rest intervals, and equal total duration. The conditioning activity (drop jump) is performed at maximal intensity with individualized box height and standardized technique. The study focuses exclusively on female athletes and includes evaluator blinding, addressing gaps in research and improving control of psychophysiological influences on performance.
Active Comparator: Control Condition
In the control condition, only the standardized warm-up will be performed. However, the total duration will be adjusted to match the other conditions, with no additional intervention. In other words, if the conditioning activity and SHAM conditions last 25 minutes (10 minutes of standardized warm-up + 15 minutes of the conditioning activity itself), in the control condition participants will perform the standardized warm-up repeatedly until reaching 25 minutes.
This study uses a randomized crossover design in which participants complete three conditions (real conditioning activity, SHAM, and control), reducing inter-individual variability. A key feature is the SHAM condition designed to control for placebo and expectancy effects, combining low-load resistance exercise (20% 1RM), verbal suggestion, and simulated blood flow restriction (15 mmHg), insufficient to induce physiological responses. All conditions are strictly standardized, including a warm-up, metronome-controlled cadence, fixed rest intervals, and equal total duration. The conditioning activity (drop jump) is performed at maximal intensity with individualized box height and standardized technique. The study focuses exclusively on female athletes and includes evaluator blinding, addressing gaps in research and improving control of psychophysiological influences on performance.
Sham Comparator: Sham Condition

The SHAM condition will be performed using the free-weight squat with a load of 20% of 1RM, i.e., a "simulated" conditioning activity insufficient to induce physiological effects. Three sets will be performed, with three-minute intervals between them. During these intervals, pneumatic tourniquets (77 × 21.5 cm) will be placed on the proximal portion of the thighs and inflated to (only) 15 mmHg for 3 minutes (including 30 seconds before and after for placement and removal).

Movement cadence will be controlled using a metronome, ensuring that participants perform the movement in synchrony with the auditory signal. The adopted cadence will be 20/20, i.e., 2 seconds for the eccentric phase and 2 seconds for the concentric phase, totaling 4 seconds per repetition.

Players will receive verbal suggestion that this technique is expected to improve performance with less fatigue compared to the "heavy" exercise, referring to the "real" conditioning activity condition.

This study uses a randomized crossover design in which participants complete three conditions (real conditioning activity, SHAM, and control), reducing inter-individual variability. A key feature is the SHAM condition designed to control for placebo and expectancy effects, combining low-load resistance exercise (20% 1RM), verbal suggestion, and simulated blood flow restriction (15 mmHg), insufficient to induce physiological responses. All conditions are strictly standardized, including a warm-up, metronome-controlled cadence, fixed rest intervals, and equal total duration. The conditioning activity (drop jump) is performed at maximal intensity with individualized box height and standardized technique. The study focuses exclusively on female athletes and includes evaluator blinding, addressing gaps in research and improving control of psychophysiological influences on performance.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Countermovement Jump Height
Time Frame: Baseline (pre-intervention) following each experimental condition within the same session.
Countermovement jump height (cm), assessed under standardized conditions using a contact mat. Participants will perform three attempts, and the mean value will be used for analysis. Jumps will be executed with hands on hips to minimize upper-body contribution. Measurements will be collected at baseline and after each experimental condition to evaluate changes in performance.
Baseline (pre-intervention) following each experimental condition within the same session.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Agility Performance
Time Frame: Baseline (pre-intervention) and after the countermovement jump assessment (following each experimental condition).
Agility performance assessed by the 5-10-5 change of direction test (seconds), measured under standardized conditions using photocell timing gates. Participants will perform three attempts, and the mean time will be used for analysis. The test consists of sprinting 5 meters to one side, 10 meters to the opposite side, and 5 meters back to the starting point. Measurements will be collected at baseline and after each experimental condition.
Baseline (pre-intervention) and after the countermovement jump assessment (following each experimental condition).
Participant Expectation
Time Frame: Post-intervention (after each condition).
Participant expectation assessed using a bipolar Visual Analog Scale (-500 to +500), used to quantify perceived effectiveness and potential placebo/nocebo effects. Participants will rate their expected change in performance following each experimental condition. Assessments will be conducted immediately after each condition and prior to performance testing.
Post-intervention (after each condition).

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Gustavo Ribeiro da Mota, PhD, Federal University of Triângulo Mineiro

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

May 10, 2026

Primary Completion (Estimated)

August 20, 2026

Study Completion (Estimated)

November 25, 2026

Study Registration Dates

First Submitted

April 14, 2026

First Submitted That Met QC Criteria

April 14, 2026

First Posted (Actual)

April 21, 2026

Study Record Updates

Last Update Posted (Actual)

April 23, 2026

Last Update Submitted That Met QC Criteria

April 20, 2026

Last Verified

April 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Individual participant data will not be shared due to privacy and confidentiality considerations. The dataset is small and may allow participant identification.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe